Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
Did you mean: (ASIN Beck disease)?
(Kashin Beck disease)
348 results
  • The effectiveness of treatments for Kashin-Beck disease: a systematic review and network meta-analysis. [Journal Article]
    Clin Rheumatol 2019Zou K, Hu J, … Zhang W
  • CONCLUSIONS: Selenium supplement has demonstrated some benefits for structural improvement of the disease in children. Chondroitin, glucosamine, IAH and nonsteroid anti-inflammatory drugs are effective for symptom improvements of KBD in adults. Evidence of surgical and complementary treatments for symptoms and aspirin and vitamin C for structure has yet to be established. Key Points • There were 23 nutraceuticals, pharmaceuticals and surgical and complementary treatments assessed for Kashin-Beck disease (KBD) in randomised trials. • Among the 23 treatments, chondroitin, glucosamine, IAH and non-steroid anti-inflammatory drugs are more effective than placebo to relieve symptoms for adults with KBD. • Selenium supplement is more effective than placebo for radiographic improvement in children or adolescents. • The efficacy of surgeries, aspirin, vitamin C and complementary treatments for KBD has not been established yet.
  • The role of the fibroblast growth factor family in bone-related diseases. [Review]
    Chem Biol Drug Des 2019Wang J, Liu S, … Yi Z
  • Fibroblast growth factor (FGF) family members are important regulators of cell growth, proliferation, differentiation, and regeneration. The abnormal expression of certain FGF family members can cause skeletal diseases, including achondroplasia, craniosynostosis syndrome, osteoarthritis, and Kashin-Beck disease. Accumulating evidence shows that FGFs play a crucial role in the growth and prolifera…
New Search Next